Emergent BioSolutions Inc.: Form 8-K, filed Nov 6, 2024
Filed with the SEC on Nov 6, 2024 and accepted by EDGAR at Nov 6, 2024, 16:12 ET.
Items reported
- Item 2.02 Results of operations
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001367644-24-000176. Last ingested by Listed: Nov 2, 2026, 16:45 ET. Listed shows no prices and gives no investment advice.